Based on the Tukey-Kramer post-hoc test, CD4+CD25+high T-cell apoptosis in recent-onset T1D subjects differed significantly from all other clinical groups except from the high at-risk group Figure 2a. The gene discussed is CD4; the disease is type 1 diabetes mellitus.